Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
- Professor of Epidemiology and Public Health
- Epidemiology & Public Health
- Institute of Epidemiology & Health
- Faculty of Population Health Sciences
Professor Hemingway's research focuses on cardiovascular disease in populations. Broadly the aim is to generate new research evidence at multiple stages in translational pathways for improving our understanding of why cardiovascular diseases occur, and then progress, in ways which can have an impact on clinical practice, healthcare and public health policy. A key element of the approach of his work is to exploit new opportunities for large scale research arising from linking electronic health records, including research on cardiovascular disease in populations. There are three strands to this work which is funded by the Wellcome Trust, Medical Research Council, National Institute of Health Research and the European Commission Framework Programme 7: novel clinical cohorts, exploitation of linked electronic health records and methods development. The Clinical Cohorts in Coronary disease Collaboration (4C) is phenotyping and genotyping people with suspected and confirmed stable coronary disease, with follow-up for cardiovascular endpoints. Cardiovascular disease research using Linked Bespoke studies and Electronic Records (CALIBER) has curated linkages between multiple sources of records, including the primary care record in CPRD (Clinical Practice Research Datalink), hospital discharge data, differentiated acute coronary syndrome endpoints from MINAP (Myocardial Ischaemia National Audit Project) and death records. The MRC-funded Prognosis Research Strategy initiative (PROGRESS) is an international, interdisciplinary collaboration developing understanding in research into prognostic factors, risk prediction models and predictors of differential treatment response. Professor Hemingway is the Director of the Farr Institute of Health Informatics Research at UCL Partners, the newly established Centre for Health service and Academic Partnership in Translational E-Health Research. One of four E-Health Informatics Research Centres, the Farr Institute at UCL Partners is funded by 10 UK bodies (including MRC, Wellcome Trust, NIHR, British Heart Foundation) and is a key aspect of the UK Government’s Life Sciences strategy.
At UCL Harry Hemingway chairs the Departmental Teaching Committee (2002-) and Joint Departmental Teaching Committee (2006-) overseeing the teaching of epidemiology and public health at undergraduate and postgraduate levels across the Division of Population Health. Nationally he has established a new short course (with MRC funding for the PROGRESS initiative) on prognosis research. Internationally he teaches courses on 'Markers and prognosis research' at the National Institute for Health Evaluative Sciences, Erasmus University, The Netherlands.
|2005||FFPH||Fellow of the Faculty of Public Health||Royal College of Physicians|
|2005||FRCP||Fellow of the Royal College of Physicians||Royal College of Physicians|
|1995||MSc||Master of Science||London School of Hygiene and Tropical Medicine|
|1988||MB.ChB||Bachelor of Medicine, Bachelor of Surgery||University of Cambridge|
|1985||BA||Bachelor of Arts||University of Cambridge|